P.H.B. Willemse

Serum CA 125, Carcinoembryonic Antigen, and CA 19-9 as Tumor Markers in Borderline Ovarian Tumors

M.J.A. Engelen, H.W.A. de Bruijn, Harrie Hollema et al. · Gynecologic Oncology · 2000 · 133 citations

Medicine, Gynecology, Oncology +17

Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.

Hjg Arts, D Katsaros, Elisabeth G.E. de Vries et al. · PubMed · 1999 · 113 citations

Medicine, Oncology, Pharmacology +16

Intraperitoneal human recombinant interferon alpha-2b in minimal residual ovarian cancer

P.H.B. Willemse, Elisabeth G.E. de Vries, Nanno H. Mulder et al. · European Journal of Cancer and Clinical Oncology · 1990 · 63 citations

Medicine, Oncology, Surgery +14

Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer

N. H. Mulder, Dirk Th. Sleijfer, P.H.B. Willemse et al. · European Journal of Cancer · 1993 · 27 citations

Medicine, Oncology, Breast Oncology +13